Companies: 10,795·Total market cap: $144.5T
Labcorp Holdings Inc.

Labcorp Holdings Inc.

LHNYSEHealthcare● Active
$263.35
$-1.81(-0.68%)
Market Cap$21.6B
P/E Ratio
52W High$293.72
52W Low$241.81

Labcorp Holdings Inc. (LH) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · LH · as of Jun 8, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

20

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Labcorp Holdings Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

LH insider buying and selling by quarter

LH insider selling · LH insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
235K117K0
2025 Q3
2025 Q4
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · LH ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

LH executive sell shares · LH board member insider trading · LH insider trading SEC filing

Showing 73 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Schechter Adam H

President & CEO · Director

Sale

Date

May 11

Shares

5,903

Price

$254.50

Value

$1.50M ⚡

View Form 4 on SEC.gov

Schechter Adam H

President & CEO · Director

Award

Date

Mar 26

Shares

58,470

Price

Value

View Form 4 on SEC.gov

Schechter Adam H

President & CEO · Director

Other

Date

Mar 26

Shares

26,106

Price

$268.38

Value

$7.01M ⚡

View Form 4 on SEC.gov

GRAHAM ANITA Z

EVP, CHRO

Award

Date

Mar 26

Shares

6,604

Price

Value

View Form 4 on SEC.gov

GRAHAM ANITA Z

EVP, CHRO

Other

Date

Mar 26

Shares

2,879

Price

$268.38

Value

$773K

View Form 4 on SEC.gov

Schroeder Mark S

EVP, Pres Diagnostics & COO

Award

Date

Mar 26

Shares

9,304

Price

Value

View Form 4 on SEC.gov

Schroeder Mark S

EVP, Pres Diagnostics & COO

Award

Date

Mar 26

Shares

2,968

Price

Value

View Form 4 on SEC.gov

Schroeder Mark S

EVP, Pres Diagnostics & COO

Other

Date

Mar 26

Shares

1,468

Price

$268.38

Value

$394K

View Form 4 on SEC.gov

Schroeder Mark S

EVP, Pres Diagnostics & COO

Other

Date

Mar 26

Shares

4,600

Price

$268.38

Value

$1.23M ⚡

View Form 4 on SEC.gov

Caveney Brian J

EVP, Pres of ED, CMO & CSO

Award

Date

Mar 26

Shares

9,304

Price

Value

View Form 4 on SEC.gov

Caveney Brian J

EVP, Pres of ED, CMO & CSO

Award

Date

Mar 26

Shares

1,986

Price

Value

View Form 4 on SEC.gov

Caveney Brian J

EVP, Pres of ED, CMO & CSO

Other

Date

Mar 26

Shares

863

Price

$268.38

Value

$232K

View Form 4 on SEC.gov

Caveney Brian J

EVP, Pres of ED, CMO & CSO

Other

Date

Mar 26

Shares

4,042

Price

$268.38

Value

$1.08M ⚡

View Form 4 on SEC.gov

Wilkinson Peter J

SVP, Chief Accounting Officer

Award

Date

Mar 26

Shares

2,388

Price

Value

View Form 4 on SEC.gov

Wilkinson Peter J

SVP, Chief Accounting Officer

Other

Date

Mar 26

Shares

755

Price

$268.38

Value

$203K

View Form 4 on SEC.gov

Wilkinson Peter J

SVP, Chief Accounting Officer

Sale

Date

Mar 27

Shares

1,633

Price

$267.05

Value

$436K

View Form 4 on SEC.gov

Vaughn Bryan T

EVP, Diagnostics

Award

Date

Mar 26

Shares

1,584

Price

Value

View Form 4 on SEC.gov

Vaughn Bryan T

EVP, Diagnostics

Other

Date

Mar 26

Shares

451

Price

$268.38

Value

$121K

View Form 4 on SEC.gov

van der Vaart Sandra D

EVP, Corporate Affairs

Award

Date

Mar 26

Shares

6,382

Price

Value

View Form 4 on SEC.gov

van der Vaart Sandra D

EVP, Corporate Affairs

Other

Date

Mar 26

Shares

2,722

Price

$268.38

Value

$731K

View Form 4 on SEC.gov

Summy Amy B.

EVP, Chief Marketing Officer

Award

Date

Mar 26

Shares

3,994

Price

Value

View Form 4 on SEC.gov

Summy Amy B.

EVP, Chief Marketing Officer

Other

Date

Mar 26

Shares

1,836

Price

$268.38

Value

$493K

View Form 4 on SEC.gov

Oyegunwa Akinbolade

EVP, CIO & CTO

Award

Date

Mar 26

Shares

1,340

Price

Value

View Form 4 on SEC.gov

Oyegunwa Akinbolade

EVP, CIO & CTO

Other

Date

Mar 26

Shares

382

Price

$268.38

Value

$103K

View Form 4 on SEC.gov

Meltzer Jonathan C

EVP, Operations

Award

Date

Mar 26

Shares

2,388

Price

Value

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About LH insider trading

LH insider trades

Labcorp Holdings Inc. (LH) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Schechter Adam H (President & CEO · Director), Caveney Brian J (EVP, Pres of ED, CMO & CSO), Wilkinson Peter J (SVP, Chief Accounting Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. LH insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Labcorp Holdings Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

LH insider trading · 5 questions

The insiders of Labcorp Holdings Inc. (LH) include executives and directors such as Schechter Adam H (President & CEO · Director), Caveney Brian J (EVP, Pres of ED, CMO & CSO), Wilkinson Peter J (SVP, Chief Accounting Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

LH board member insider tradingwho are LH insidersLH insider rosterLabcorp Holdings Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026